Radiation retinopathy intricacies and advances in management. (19th May 2022)

• Record Type: Journal Article
• Authors: García-O'Farrill, Noraliz; Pugazhendhi, Sangeethabalasri; Karth, Peter A.; Hunter, Allan A.
• Is Part Of: Seminars in ophthalmology. Volume 37:Number 4(2022)
• Page Start: 417
• Page End: 435
• Publication Date: 2022-05-19
• Subjects: Radiation retinopathy -- maculopathy -- Intravitreal anti-VEGF -- corticosteroids -- bevacizumab -- aflibercept; Ophthalmology -- Periodicals; Eye -- Diseases -- Periodicals; Eye -- Surgery -- Periodicals; 617.7005
• DOI: 10.1080/08820538.2021.2000623
• Languages: English
• ISSNs: 0882-0538

Abstract

ABSTRACT: Background: Radiation retinopathy is a chronic, progressive, vision-threatening complication from exposure to various radiation sources. While several treatment modalities are available, proper management for this disease is a continuing challenge with no consensus on the most efficacious. Objective: The aim of this article is to provide an updated review of the published literature on the course of the disease, available treatments and their efficacies, frequency of regimen, core issues in patient management, and additional newer treatment modalities, including possible prophylactic approaches. Value: We also highlighted the challenges encountered with managing chronically treated patients through an analysis of a clinical case report on a patient who was treated for several years with different modalities after a diagnosis of radiation retinopathy.